AKT1 and posterior cortical atrophy: Metformin downregulates IGF‐1R expression hence reducing downstream activation of AKT,46, 58 whereas ARSIs or ADT reduces AR signalling,3 therefore the combination of both could potentially inhibit the cross regulation of the two main oncogenic signalling pathways driving PCa growth.